Evidence map›Paper›PMID 26210009›Full record

SynthesisThe International journal on drug policy2015

Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence.

Afarin Rahimi-Movaghar, Masoumeh Amin-Esmaeili, Behrang Shadloo, Alireza Noroozi, Mohsen Malekinejad

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The International journal on drug policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2015
    Pooled it
  5. Article
  6. Article
  7. Rats chasing the dragon: A new heroin inhalation method.Journal of neuroscience methods · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Substance use & misuse · 2019
    Article
  18. Article
  19. Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico.Journal of urban health : bulletin of the New York Academy of Medicine · 2018
    Article
  20. Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future.Journal of urban health : bulletin of the New York Academy of Medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Afarin Rahimi-MovagharIranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, No. 486, South Karegar Ave., Postal Code: 1336616357, Tehran, Iran.
Masoumeh Amin-EsmaeiliIranian Research Center for HIV/AIDS (IRCHA), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Imam Khomeini Hospital, Keshavarz Blvd., Postal code: 14197-33141, Tehran, Iran.
Behrang ShadlooIranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, No. 486, South Karegar Ave., Postal Code: 1336616357, Tehran, Iran.
Alireza NorooziIranian National Center for Addiction Studies (INCAS), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, No. 486, South Karegar Ave., Postal Code: 1336616357, Tehran, Iran; School of Advanced Technologies of Medicine, Tehran University of Medical Sciences, Iran.
Mohsen MalekinejadInstitute for Health Policy Studies and Global Health Sciences, University of California San Francisco, 3333 California Street, Suite 265, San Francisco, CA 94118, USA. Electronic address: MMalekinejad@ucsf.edu.
Tehran University of Medical Sciences · IRImam Khomeini Hospital · IRUniversity of California, San Francisco · US

Funding

Crucial Transitions among Young Opioid Users in IranR21DA029473 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALEKINEJAD, MOHSEN · 2010 to 2011
$322k
NIDA NIH HHS 1R21DA029473-01NIDA NIH HHS R21 DA029473
6 · The paper itself

Abstract

backgroundInjection drug use, a behavior associated with significant adverse health effects, has been increasing over the past decade in Iran. This study aims to systematically review the epidemiological and qualitative evidence on factors that facilitate or protect the transition to injection drug use in Iran.

methodsWe conducted electronic searches in five international (Medline, Web of Science, EMBASE, CINAHL, PsycINFO), one regional (IMEMR) and three Iranian (Iranmedex, Iranpsych, IranDoc) databases, as well as contacting experts in the field. Two trained researchers screened documents to identify relevant studies and independently dual-extracted data following pre-specified protocol. We applied principles of thematic analysis for qualitative data and applied a random effect meta-analysis model for age of first injection.

resultsA total of 38 documents from 31 studies met eligibility criteria, from which more than 50% were implemented from 2006 to 2008. The weighted mean age of first injection was 25.8 (95% Confidence Interval: 25.3-26.2). Between 1998 and 2011, the age of first injection was relatively stable. Overall, drug users had used drugs for 6-7 years before they started injection use. Heroin was the first drug of injection in the majority of the cases. We identified factors influencing the initiation of or transition to injection use at various levels, including: (1) individual (pleasure-seeking behavior, curiosity and development of drug dependency commonly reported), (2) social and environmental (role of peer drug users in the first injection use, the economic efficiency associated with injections and the wide availability of injectable form of drugs in the market).

conclusionHarm reduction policies in Iran have almost exclusively focused on drug injectors in Iran. However, given the extent of the non-injection drug use epidemic, evidence from this study can provide insight on points of interventions for the prevention of the transition to injection use.

Indexed as

Age of OnsetHarm ReductionHeroin DependenceHumansIranSubstance Abuse, IntravenousSubstance-Related DisordersFirst injection episodeHarm reductionIranProtective factors for injectingRisk factors for injectingSubstance useSystematic review

Identifiers

PMID26210009
PMCPMC4625838
OpenAlexW2115604070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.